Transcription of Annual Report 2017 - テルモ
{{id}} {{{paragraph}}}
Example: stock market
Annual Report 2017 - テルモ
Annual Report 2017 Terumo Corporation Terumo Corporation October 2017 17T333 Printed in JapanTokyo Of ceTokyo Opera City Tower, 3-20-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-1450, JapanKeeping Patients and Medical Professionals at the Center of Everything We DoTo fulfill its corporate mission of Contributing to Society through Healthcare, Terumo continually rises to the challenge of delivering outstanding innovation to patients and medical Communication Tools Mid- to Long-term Growth Strategy, Business Activities, and Financial InformationAnnual ReportJapanese, EnglishPrinted, PDFF inancial InformationEnglishPDFS ustainability ReportJapanese, EnglishPDFE nvironmental and Social Mission, Five Statements and Global VisionBusiness OverviewA History of Creating ValueMessage from the President and CEOC ardiac and Vascular CompanyGeneral Hospital CompanyBlood Management Company (Terumo BCT)Focus: Growth Strategy in Emerging CountriesAbout
5 Terumo Corporation Annual Report 2017 As a global leader in blood component, therapeutic apheresis, and cellular tech - nologies, the Blood Management Company (Terumo BCT) is …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
EXECUTIVE SUMMARY CONCLUSIONS AND POLICY, World Drug Report 2017, World, COLOMBIA, Drug, World Drug Report, Colombia Drug Report 2017, COUNTERING PREJUDICES ABOUT PEOPLE WHO, World Drug, 2017 REPORT COUNTERING PREJUDICES ABOUT PEOPLE WHO, Report, Final Report DRUG-RESISTANT INFECTIONS, 2017, Turkey - Country Drug Report 2017, Drug Report 2017, France - Country Drug Report 2017, Orphan Drug Report 2017, EP Vantage 2017 Preview, Drug REPORT